SIM
ITCI

Sonora Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sonora Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.38M Buy
90,531
+4,250
+5% +$148K 0.42% 68
2021
Q2 		$3.52M Buy
86,281
+13,633
+19% +$504K 0.46% 68
2021
Q1 		$2.46M Buy
72,648
+1,943
+3% +$67.4K 0.19% 132
2020
Q4 		$2.25M Buy
70,705
+11,770
+20% +$309K 0.19% 131
2020
Q3 		$1.51M Buy
58,935
+38,785
+192% +$885K 0.14% 138
2020
Q2 		$517K Buy
+20,150
New +$408K 0.05% 181

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sonora Investment Management's ITCI Position: Q3 2021 in Review

Sonora Investment Management increased its Intra-Cellular Therapies Inc. (ITCI) stake by 4.9% in Q3 2021, buying an estimated $148K and bringing the position to 90,531 shares worth $3.38M. The position accounts for 0.42% of the portfolio, ranked #68.

Sonora Investment Management first reported a position in ITCI in Q2 2020 and has held it in 6 quarters since. The position peaked at $3.52M in Q2 2021. 180 funds tracked by Wall St. Rank hold ITCI as of Q3 2021.

  • Sonora Investment Management held 90,531 shares of Intra-Cellular Therapies Inc. worth $3.38M as of Q3 2021.
  • Sonora Investment Management bought 4,250 Intra-Cellular Therapies Inc. shares in Q3 2021, an estimated $148K.
  • Intra-Cellular Therapies Inc. made up 0.42% of Sonora Investment Management's portfolio in Q3 2021, its #68 holding.
  • Sonora Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and has held it in 6 quarters since.
  • Sonora Investment Management's Intra-Cellular Therapies Inc. position peaked at $3.52M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.